Rosebank Industries (ROSE) Acquisition presentation summary
Event summary combining transcript, slides, and related documents.
Acquisition presentation summary
14 Apr, 2026Executive summary
Opportunity to acquire MW Components and CPM, two high-quality businesses with strong market positions and differentiated technology, at appropriate valuations.
Both targets fit the "Buy, Improve, Sell" strategy, with significant potential for margin expansion and value creation.
Targeted operating margin expansion of 6-7 percentage points for both businesses, aiming to double shareholder investment in 3-5 years.
ECI, the first acquisition, is performing ahead of expectations, supporting the value creation playbook.
Intention to step up to the main market of the London Stock Exchange in Q2 2026, with expected FTSE250 inclusion.
Transaction overview
Combined enterprise value for MW Components and CPM is $3.05bn, with a potential $200m earn-out linked to CPM's FY26 performance.
MW Components FY25 revenue: $500m, adjusted EBITDA: $95m (19% margin); CPM FY25 revenue: $713m, adjusted EBITDA: $175m (25% margin).
Acquisition funded by ~$750m debt and £1.9bn (~$2.6bn) equity raise.
Pro-forma acquisition leverage expected at ~2.75x.
MW Components: business and improvement plan
Leading US provider of precision metal components, with strong brands and blue-chip customers in aerospace, defense, and industrial markets.
FY25 group revenue: $500m; adjusted operating profit: $77m; margin: 15.4%.
Improvement plan includes head office efficiencies, facility optimization, footprint rationalization, contract renegotiation, scaling aerospace/defense exposure, and reducing debt.
Targeting operating margin increase from 15% to 21-22% and significant head office cost savings ($10-15m).
Plan to accelerate growth in high-margin aerospace/defense and improve profitability by consolidating sites and exiting unprofitable contracts.
Latest events from Rosebank Industries
- $1.9bn ECI acquisition drives $445m revenue, $57m adjusted profit, and 2.4x leverage.ROSE
H2 202514 Apr 2026 - Experienced team targets value creation in industrials via proven 'Buy, Improve, Sell' strategy.ROSE
Investor presentation14 Apr 2026 - Statutory operating loss of £9.5m, £48.1m cash retained, and first acquisition targeted.ROSE
H2 202414 Apr 2026 - ECI acquisition completed; H1 2025 adjusted loss £2.2m, record ECI margins, strong cash position.ROSE
H1 202514 Apr 2026 - Acquired ECI for $1.9bn, targeting margin growth and further value-creating acquisitions.ROSE
Investor presentation14 Apr 2026 - Confident in achieving 2025 targets with strong margin growth and active M&A pursuit.ROSE
Trading update14 Apr 2026